InsidersTradesSigma
Follow the 한미사이언스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 한미사이언스 has recorded 35 public disclosures. Market capitalisation: €3,101.3bn. The latest transaction was reported on 1 September 2026 (Purchase). Among the most active insiders: 송영숙. All data is free.
17
Insider Decl.
n/a
Thresholds
€322m
6 ops.
Buy Volume
€82m
3 ops.
Sell Volume
Fundamental score
Ranked 15,787 of 29,057 companies
49.7
score / 100
Value41
Quality59
FCF yld0.9%
Earn yld3.8%
EV/EBITDA21.7x
ROE16%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations35 total
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
25 of 35 declarations
Acerca de 한미사이언스
Hanmi Science es una empresa surcoreana centrada en el sector sanitario y farmacéutico. Cotiza en el mercado XKRX.